nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Drospirenone—BCHE—malignant glioma	0.374	0.374	CrCbGaD
Potassium Canrenoate—Methyltestosterone—CYP2B6—malignant glioma	0.287	0.287	CrCbGaD
Potassium Canrenoate—Drospirenone—PTGS2—malignant glioma	0.172	0.172	CrCbGaD
Potassium Canrenoate—Testosterone—CYP2B6—malignant glioma	0.167	0.167	CrCbGaD
